Integrated proteogenomic characterization of medullary thyroid carcinoma.
Shi X, Sun Y, Shen C, Zhang Y, Shi R, Zhang F, Liao T, Lv G, Zhu Z, Jiao L, Li P, Xu T, Qu N, Huang N, Hu J, Zhang T, Gu Y, Qin G, Guan H, Pu W, Li Y, Geng X, Zhang Y, Chen T, Huang S, Zhang Z, Ge S, Wang W, Xu W, Yu P, Lu Z, Wang Y, Guo L, Wang Y, Guo T, Ji Q, Wei W.
Shi X, et al.
Cell Discov. 2022 Nov 8;8(1):120. doi: 10.1038/s41421-022-00479-y.
Cell Discov. 2022.
PMID: 36344509
Free PMC article.
Furthermore, we explored putative therapeutic targets of each proteomic subtype, and found that two tenascin family members TNC/TNXB might serve as potential prognostic biomarkers for MTC. Collectively, our study expands the knowledge of MTC biology and therapeutic vulnera …
Furthermore, we explored putative therapeutic targets of each proteomic subtype, and found that two tenascin family members TNC/TNXB …